Put PDE5 Inhibitor Risks in Perspective

June 2022

More data linking PDE5 inhibitors (sildenafil, etc) to eye problems will raise questions about safety.

Labels already warn of rare optic neuropathy...which can cause loss of vision that may be permanent.

New evidence suggests that this and other serious eye conditions (retinal detachment, etc) occur in about 16 in 10,000 patients per year on a PDE5 inhibitor...higher than prior estimates.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Aspirin Clear Up Confusion About Aspirin for CV Primary Prevention
Bites & Stings Answer Questions About Insect and Tick Repellents
Heart Failure Clarify New Heart Failure Terms and Management
Psychiatry Use a Practical Approach to Manage Agitation in Dementia
Med Safety Put PDE5 Inhibitor Risks in Perspective
Insomnia Quell Hype About New Quviviq for Insomnia
Travel Medicine Share Strategies to Prevent Blood Clots When Traveling
Cancer Help Overcome Barriers to Opioid Use for Cancer Pain
IBS Watch for Ibsrela for Irritable Bowel Syndrome

Put PDE5 Inhibitor Risks in Perspective

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents